Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.4 (
trypsin
)
42,187
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the course of a study of UDP-xylose:proteoglycan core protein xylosyltransferase (EC 2.4.2.26), another xylosyltransferase was discovered in the soluble fraction of a rat kidney homogenate. The latter enzyme catalyzed [3H]xylosyl transfer from UDP-[3H]xylose to an endogenous acceptor and yielded a product in which the xylose was bound by an alkali-stable linkage. It was therefore concluded that the acceptor was not the core protein of one of the proteoglycans containing a xylose-->serine linkage, since this linkage is cleaved by alkali. The [3H]xylose-labeled product emerged with the void volume when chromatographed on Sephadex G-50, it was precipitated by trichloroacetic acid, and it had a mobility on sodium dodecyl sulfate-polyacrylamide gel electrophoresis corresponding to a molecular mass of about 32,000 Da. Digestion with
trypsin
or alpha-amylase degraded the labeled product to small fragments, as determined by gel chromatography, suggesting that it was a glycoprotein related to glycogen. A product of similar characteristics was formed when UDP-[3H]glucose was substituted for UDP-[3H]xylose as the glycosyl donor, and the two nucleotide sugars were mutually competitive in the respective transfer reactions, indicating that they were substrates for the same enzyme. On the basis of these findings, it was tentatively concluded that the xylosyltransferase and its acceptor were the renal form of
glycogenin
.
...
PMID:Xylosyl transfer to an endogenous renal acceptor. Characteristics of the reaction and properties of the product. 815 79
Proteoglycogen
glycogenin
is linked to the glucose residue of the C-chain reducing end of glycogen. We describe for the first time the release by isoamylase and isolation of C-chain-bound
glycogenin
(C-glycogenin) from proteoglycogen. The treatment of proteoglycogen with alpha-amylase releases monoglucosylated and diglucosylated
glycogenin
(a-glycogenin) which is able to autoglucosylate. It had been described that isoamylase splits the glucose-
glycogenin
linkage of fully autoglucosylated
glycogenin
previously digested with
trypsin
, releasing the maltosaccharide moiety. It was also described that carbohydrate-free apo-
glycogenin
shows higher mobility in SDS-PAGE and twice the autoglucosylation capacity of partly glucosylated
glycogenin
. On the contrary, we found that the C-
glycogenin
released from proteoglycogen by isoamylolysis shows lower mobility in SDS-PAGE and about half the autoglucosylation acceptor capacity of the partly glucosylated a-
glycogenin
. This behavior is consistent with the release of maltosaccharide-bound
glycogenin
instead of apo-
glycogenin
. No label was split from auto-[14C]glucosylated C-
glycogenin
or fully auto-[14C]glucosylated a-
glycogenin
subjected to isoamylolysis without previous trypsinolysis, thus proving no hydrolysis of the maltosaccharide-tyrosine linkage. The ability of C-
glycogenin
for autoglucosylation would indicate that the size of the C-chain is lower than the average length of the other glycogen chains.
...
PMID:C-chain-bound glycogenin is released from proteoglycogen by isoamylase and is able to autoglucosylate. 1276 2